Nearly two years after the Supreme Court struck down its gene patents, DNA testing company Myriad is fighting to sustain its business model.
WSJ.com: What's News US, Wall Street Journal
Sun, 05/03/2015 - 2:33am
Nearly two years after the Supreme Court struck down its gene patents, DNA testing company Myriad is fighting to sustain its business model.